ARA - American Renal Associates Holdings, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5201.93M
Enterprise Value 31.02B
Trailing P/E N/A
Forward P/E 113.50
PEG Ratio (5 yr expected) 13.75
Price/Sales (ttm)0.25
Price/Book (mrq)N/A
Enterprise Value/Revenue 31.25
Enterprise Value/EBITDA 65.88

Trading Information

Stock Price History

Beta (3Y Monthly) 2.06
52-Week Change 3-69.90%
S&P500 52-Week Change 31.68%
52 Week High 323.49
52 Week Low 35.48
50-Day Moving Average 37.14
200-Day Moving Average 38.07

Share Statistics

Avg Vol (3 month) 3174.87k
Avg Vol (10 day) 3104.9k
Shares Outstanding 532.07M
Float 13.83M
% Held by Insiders 139.59%
% Held by Institutions 10.51%
Shares Short (Jul 31, 2019) 41.93M
Short Ratio (Jul 31, 2019) 411.99
Short % of Float (Jul 31, 2019) 4N/A
Short % of Shares Outstanding (Jul 31, 2019) 45.94%
Shares Short (prior month Jun 28, 2019) 41.89M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 31.30
Trailing Annual Dividend Yield 319.58%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018

Profitability

Profit Margin -1.98%
Operating Margin (ttm)16.51%

Management Effectiveness

Return on Assets (ttm)8.78%
Return on Equity (ttm)21.70%

Income Statement

Revenue (ttm)817.25M
Revenue Per Share (ttm)25.73
Quarterly Revenue Growth (yoy)12.40%
Gross Profit (ttm)262.77M
EBITDA 174.1M
Net Income Avi to Common (ttm)-15.65M
Diluted EPS (ttm)-0.49
Quarterly Earnings Growth (yoy)-68.80%

Balance Sheet

Total Cash (mrq)62.9M
Total Cash Per Share (mrq)1.93
Total Debt (mrq)553.96M
Total Debt/Equity (mrq)228.36
Current Ratio (mrq)1.03
Book Value Per Share (mrq)-2.26

Cash Flow Statement

Operating Cash Flow (ttm)115.05M
Levered Free Cash Flow (ttm)82.53M